These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22360679)

  • 1. Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation.
    Ishida F; Ko YH; Kim WS; Suzumiya J; Isobe Y; Oshimi K; Nakamura S; Suzuki R
    Cancer Sci; 2012 Jun; 103(6):1079-83. PubMed ID: 22360679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia.
    Jung KS; Cho SH; Kim SJ; Ko YH; Kang ES; Kim WS
    J Hematol Oncol; 2016 Apr; 9():41. PubMed ID: 27091029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features and treatment of aggressive natural killer cell leukemia: case series and literature review.
    Ni Y; Li L; Wang Y; Sun L
    Turk J Pediatr; 2024 Oct; 66(4):481-489. PubMed ID: 39387420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Allogeneic stem cell transplantation for aggressive NK cell leukemia].
    Fujimoto A
    Rinsho Ketsueki; 2021; 62(5):360-368. PubMed ID: 34108314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favorable outcome in a child with EBV-negative aggressive NK cell leukemia.
    Park JA; Jun KR; Nam SH; Ghim TT
    Int J Hematol; 2013 May; 97(5):673-6. PubMed ID: 23550023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Treatment of Pediatric Epstein-Barr Virus-positive Aggressive Natural Killer-Cell Leukemia.
    Kim BK; Hong KT; Kang HJ; An HY; Choi JY; Hong CR; Park KD; Lee DS; Shin HY
    J Pediatr Hematol Oncol; 2019 Jul; 41(5):e336-e337. PubMed ID: 29889803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type.
    Yokoyama H; Yamamoto J; Tohmiya Y; Yamada MF; Ohguchi H; Ohnishi Y; Okitsu Y; Fukuhara N; Ohba-Ohtsuka R; Kohata K; Ishizawa K; Kameoka J; Harigae H
    Leuk Lymphoma; 2010 Aug; 51(8):1509-12. PubMed ID: 20496989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful allogeneic hematopoietic stem cell transplantation for aggressive NK cell leukemia.
    Ichikawa S; Fukuhara N; Yamamoto J; Suzuki M; Nakajima S; Okitsu Y; Kohata K; Onishi Y; Ishizawa K; Kameoka J; Harigae H
    Intern Med; 2010; 49(17):1907-10. PubMed ID: 20823655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of natural killer-cell malignancies.
    Ishida F; Kwong YL
    Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis.
    Hamadani M; Kanate AS; DiGilio A; Ahn KW; Smith SM; Lee JW; Ayala E; Chao N; Hari P; Bolaños-Meade J; Gress R; Smedegaard Anderson N; Chen YB; Farooq U; Schiller G; Yared J; Sureda A; Fenske TS; Olteanu H
    Biol Blood Marrow Transplant; 2017 May; 23(5):853-856. PubMed ID: 28161608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic stem cell transplantation for patients with aggressive NK-cell leukemia.
    Fujimoto A; Ishida F; Izutsu K; Yamasaki S; Chihara D; Suzumiya J; Mitsui T; Doki N; Sakai H; Kobayashi H; Kanda J; Fukuda T; Atsuta Y; Suzuki R
    Bone Marrow Transplant; 2021 Feb; 56(2):347-356. PubMed ID: 32778688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive natural killer cell leukemia: diagnosis, treatment recommendations, and emerging therapies.
    Zhang Y; Lee D; Gesiotto Q; Sokol L
    Expert Rev Hematol; 2021 Aug; 14(8):731-740. PubMed ID: 34263714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
    Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study.
    Yasuda S; Najima Y; Konishi T; Yamada Y; Nagata A; Takezaki T; Kaito S; Kurosawa S; Sakaguchi M; Harada K; Shingai N; Yoshioka K; Inamoto K; Mukae J; Toya T; Igarashi A; Shimizu H; Kobayashi T; Kakihana K; Sakamaki H; Kawamata N; Ohashi K; Doki N
    Leuk Res; 2021 Sep; 108():106627. PubMed ID: 34062327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of haploidentical hematopoietic stem cell transplantation in non-infant children with t(v;11q23)/MLL-rearranged B-cell acute lymphoblastic leukemia.
    Bai L; Cheng YF; Lu AD; Suo P; Wang Y; Zuo YX; Yan CH; Wu J; Jia YP; Sun YQ; Chen YH; Chen H; Liu KY; Han W; Xu LP; Wang JB; Tang XF; Chen HR; Zhang LP; Huang XJ
    Leuk Res; 2020 Apr; 91():106333. PubMed ID: 32109757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful disease control with L-asparaginase monotherapy for aggressive natural killer cell leukemia with severe hepatic failure.
    Takahashi H; Sakai R; Hattori Y; Ohshima R; Kuwabara H; Hagihara M; Enaka M; Nozawa A; Tomita N; Ishigatsubo Y; Fujisawa S
    Leuk Lymphoma; 2013 Mar; 54(3):662-4. PubMed ID: 22891745
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent progress of diagnosis and treatment in NK cell neoplasms].
    Ishida F
    Rinsho Ketsueki; 2015 Jun; 56(6):645-50. PubMed ID: 26256874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.
    Kawada H; Yoshimitsu M; Nakamura D; Arai A; Hayashida M; Kamada Y; Maekawa K; Fujino S; Arima M; Arima N; Tabuchi T; Inoue H; Hamda H; Suzuki S; Matsushita K; Arima N
    Biol Blood Marrow Transplant; 2015 Apr; 21(4):696-700. PubMed ID: 25542158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase.
    Kwong YL; Chan TSY; Tan D; Kim SJ; Poon LM; Mow B; Khong PL; Loong F; Au-Yeung R; Iqbal J; Phipps C; Tse E
    Blood; 2017 Apr; 129(17):2437-2442. PubMed ID: 28188133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.